PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Jun-2024 NLS Pharmaceutics Announces Registered Direct Offering AccessWire
28-Jun-2024 FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd. AccessWire
28-Jun-2024 Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available AccessWire
28-Jun-2024 Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution ArisGlobal
28-Jun-2024 EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R) AccessWire
28-Jun-2024 Creative Proteomics Launches Disulfide Bond Analysis Service Creative Proteomics
28-Jun-2024 Creative Proteomics Elevates Protein Research with Innovative Crosslinking Protein Interaction Analysis Service Creative Proteomics
28-Jun-2024 Proregulations Announces Participation in 29th CBA Annual Conference Proregulations
28-Jun-2024 Creative Enzymes Introduces Fermented Calcium Propionate for Superior Food Preservation Solutions Creative Enzymes
28-Jun-2024 Creative Enzymes Pioneers Enzyme Discovery for Industry Advancement Creative Enzymes
27-Jun-2024 Waystar Secures Top Spot for End-to-End Revenue Cycle Management Solutions for Hospitals, IDNs, and Health Systems in 2024 Black Book Survey AccessWire
27-Jun-2024 Panoramic Health Achieves HITRUST CSF(R) Certification for Its Data Platform AccessWire
27-Jun-2024 Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units AccessWire
27-Jun-2024 VMeDx Revolutionizes the Healthcare Industry With Top-Notch Virtual Medical Assistants AccessWire
27-Jun-2024 Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting AccessWire
27-Jun-2024 NICE recommends CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) as the first single infusion gene therapy for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors for reimbursement via a managed access agreement, recognising the treatment as cost-effective in England. CSL Behring
27-Jun-2024 The Danish Medicines Council recommends CSL Behring’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B CSL Behring
27-Jun-2024 CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital CatSci Ltd
27-Jun-2024 Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI Medivir AB
27-Jun-2024 Take Pride in your health, says London Medical Laboratory London Medical Laboratory